Literature DB >> 7922054

Localization and surgical management of insulinoma.

J G Geoghegan1, J E Jackson, M P Lewis, E R Owen, S R Bloom, J A Lynn, R C Williamson.   

Abstract

Over a 14-year period 34 patients were referred for surgical treatment of insulinoma. The diagnosis was confirmed by demonstrating hypoglycaemia with inappropriate hyperinsulinaemia during prolonged fasting. Selective visceral angiography localized 30 solitary benign insulinomas and two carcinomas. In two patients with islet cell hyperplasia, angiography demonstrated a single lesion only. Ultrasonography had a sensitivity of 15 per cent and computed tomography a sensitivity of 24 per cent in the localization of tumours. All patients but one were treated by operation. Eighteen tumours were enucleated and 13 (including both patients with islet cell hyperplasia) were treated by distal pancreatectomy. Two patients underwent negative primary exploration; both had single adenomas removed at re-exploration. There were no operative deaths but nine patients (predominantly those undergoing pancreatic resection) had complications. Thirty-one patients were symptom-free following operation at a mean follow-up of 16 months.

Entities:  

Mesh:

Year:  1994        PMID: 7922054     DOI: 10.1002/bjs.1800810733

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

Review 1.  Minimal-access approaches to complications of acute pancreatitis and benign neoplasms of the pancreas.

Authors:  T A Kellogg; K D Horvath
Journal:  Surg Endosc       Date:  2003-09-10       Impact factor: 4.584

2.  Impact of variant pancreatic arterial anatomy and overlap in regional perfusion on the interpretation of selective arterial calcium stimulation with hepatic venous sampling for preoperative localization of occult insulinoma.

Authors:  Scott M Thompson; Adrian Vella; F John Service; Clive S Grant; Geoffrey B Thompson; James C Andrews
Journal:  Surgery       Date:  2015-04-11       Impact factor: 3.982

3.  Clinical profile of insulinoma: analysis from a tertiary care referral center in India.

Authors:  Raju A Gopal; Shrikrishna V Acharya; Sunil K Menon; Tushar R Bandgar; Padma S Menon; Nalini S Shah
Journal:  Indian J Gastroenterol       Date:  2010-10-16

Review 4.  Laparoscopic pancreatic surgery for islet cell tumors of the pancreas.

Authors:  Ahmad Assalia; Michel Gagner
Journal:  World J Surg       Date:  2004-11-04       Impact factor: 3.352

5.  Accurate preoperative localization of insulinomas avoids the need for blind resection and reoperation: analysis of a single institution experience with 17 surgically treated tumors over 19 years.

Authors:  Brian K P Goh; London L P J Ooi; Peng-Chung Cheow; Yu-Meng Tan; Hock-Soo Ong; Yaw-Fui A Chung; Pierce K H Chow; Wai-Keong Wong; Khee-Chee Soo
Journal:  J Gastrointest Surg       Date:  2009-03-17       Impact factor: 3.452

Review 6.  Occult sporadic insulinoma: localization and surgical strategy.

Authors:  Bassam Abboud; Joe Boujaoude
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

7.  Management of insulinomas: analysis from a tertiary care referral center in India.

Authors:  Thomas V Paul; Jubbin J Jacob; Senthil K Vasan; Nihal Thomas; Simon Rajarathnam; Ben Selvan; M J Paul; Deepak Abraham; Aravindan Nair; M S Seshadri
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

8.  Diagnostic yield of endoscopic ultrasound in patients with hypoglicemia and insulinoma suspected.

Authors:  Félix Ignacio Téllez-Ávila; Gladys Yolanda Acosta-Villavicencio; Carlos Chan; Jorge Hernández-Calleros; Luis Uscanga; Francisco Valdovinos-Andraca; Miguel Ángel Ramírez-Luna
Journal:  Endosc Ultrasound       Date:  2015 Jan-Mar       Impact factor: 5.628

9.  Usefulness of selective arterial calcium injection tests for functional pancreatic neuroendocrine tumors.

Authors:  Yutaka Nakano; Minoru Kitago; Masahiro Shinoda; Seishi Nakatsuka; Isao Kurihara; Hiroshi Yagi; Yuta Abe; Go Oshima; Shutaro Hori; Takahiro Yokose; Yuko Kitagawa
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.